Insilico Medicine and Servier Achieve First Milestone in AI-Driven R D Collaboration, Triggering An undisclosed Milestone Payment
- Written by PR Newswire
- Two programs under the multi-year R&D collaboration have initiated and completed target nomination since its early 2026 announcement.
- Insilico reached the first R&D milestone using its proprietary Pharma.AI platform, triggering an undisclosed milestone payment from Servier.
- The multi-targets oncology collaboration of both parties, announced...
